形状记忆合金*
脊髓性肌萎缩
基因检测
医学
临床实习
计算机科学
物理疗法
内科学
算法
作者
Yulin Zhou,Yuqian Jiang
标识
DOI:10.2174/0113892029273388231023072050
摘要
Spinal muscular atrophy (SMA) is one of the most common genetic disorders worldwide, and genetic testing plays a key role in its diagnosis and prevention. The last decade has seen a continuous flow of new methods for SMA genetic testing that, along with traditional approaches, have affected clinical practice patterns to some degree. Targeting different application scenarios and selecting the appropriate technique for genetic testing have become priorities for optimizing the clinical pathway for SMA. In this review, we summarize the latest technological innovations in genetic testing for SMA, including MassArray®, digital PCR (dPCR), next-generation sequencing (NGS), and third-generation sequencing (TGS). Implementation recommendations for rationally choosing different technical strategies in the tertiary prevention of SMA are also explored.
科研通智能强力驱动
Strongly Powered by AbleSci AI